A positive correlation between CHRM2 expression and the immune cell CD8+ T-cell infiltration was found in lung, gastric, and colon, as well as liver cancer, and the CHRM3 expression was positively significantly related to CD8+ T-cell infiltration in liver and prostate cancer [190]. Here, CD8A is linked to prostate carcinoma.